Global Iron Deficiency Anemia Treatment Market By Treatment Type (Supplements & Medications/Antibiotics, Blood Transfusion, Intravenous (IV) Iron Therapy, and Others); By Gender (Male and Female); By Age Group (Pediatric, Adult, and Geriatric); By End Users (Hospitals, Ambulatory Surgical Centers, Home Care, and Others); By Region (U.S., Canada, Mexico, Rest of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, the Netherlands, Luxembourg), Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
Iron deficiency is the most common cause of anemia, however there can be different reasons for a person to suffer from iron deficiency anemia (IDA) such as lack of iron-rich food products in diet, pregnancy, inabaility of patient's body to absorb iron, and medical conditions such as celiac disease, Crohn's disease, and ulcerative colitis. Many times, surgery such as gastric bypass remove part of intestines and thus, limits the ability of patient's body to absorb iron. Hence, the increase in the number IDA patients is fuelling the growth of global iron deficiency anemia treatment. However, the concerns pertaining to side effects of iron supplements is restricting the growth of global iron deficiency anemia treatment market.
Many factors are driving the global iron deficiency anemia treatment market but the most important factor is inadequate lifestyle concerns among millennial. As many people have grown callous towards their lifestyle, improper diet is causing iron defiency in many people. Unhealthy eating habits is also contributing towards iron deficiency. According to contrite meta-analysis of available data, anemia can enhance the risk of severe COVID-19 infection. Anemia patients having low hemoglobin levels in their blood circulation system, the oxygen supply to various organ gets disrupted. This causes hypoxia, which can result in multiple organ dysfunction. Respiratory organ dysfunction is commonly observed in this situation. Multiple organ dysfunction showcase severe potencies to contribute to the development of severe outcomes in COVID-19 infection. Among patients infected with COVID-19, the state of anemia could be worsened. Hence, the demand for medicines and health supplements meant to increase the hemoglobin count in the blood showcases significant growth opportunity for the global iron deficiency anemia treatment market over the forecast period.
Absolute Market Insights reports, the global iron deficiency anemia treatment market is likely to grow at 6.2% CAGR during the 2021-2029 period, and reach a valuation of US$ 4402.36 Mn by 2029.
Global Iron Deficiency Anemia Treatment Market Revenue & Forecast, (US$ Million), 2015 – 2029
Treatment Type Outlook:
On the basis of treatment type, the global iron deficiency anemia treatment market covers supplements & medications/ antibiotics, blood transfusion, intravenous (IV) iron therapy, and others. In 2020, the supplements & medications/ antibiotics segment held the larger market share and is anticipated to retain its share during the forecast period. The primary goals of treating iron-deficiency anemia are to treat its underlying cause and ensure that normal levels of red blood cells, hemoglobin, and iron are restored. Iron supplements is among the primary treatment prescribed by doctors. Many other factors can cause anemia but nine out of ten anemia patients suffer from this ailment due to iron deficiency, which certain medicines and health supplements can compensate. Other kinds of anemia treatment are required only if iron deficiency is not the reason for anemia.
Gender Outlook:
The gender segment of global iron deficiency anemia treatment market in this report has been broadly segmented into male and female. In 2020, the female gender segment held the larger market share. The segment is anticipated to witness highest growth rate over the forecast period. Apart from pregnancy and breast-feeding, menstruation also causes iron deficiency, as many times, menstrual pain can drain women from energy that can be derived only by eating food and health supplements which are rich in iron. Therefore, many doctors advise women to include such supplements and food items in their diet.
Age Group Outlook:
The age group segment in the global iron deficiency anemia treatment market is segmented into pediatric, adult, and geriatric. In 2020, the adult category held the larger market share. Pediatric category is estimated to make progress as the fastest growing market category over the period of next eight years. Due to advancements in medical science, there are many new treatments and medicines that are suitable for both pediatric people as well as adults. Iron Dextran (INFeD) injection, an iron replacement product, along with many products similar to it, is used not only for treatment of adult patients but also for pediatric patients of age 4 months and older, provided they have documented iron deficiency. Patients who have intolerance to oral iron or an unsatisfactory response to oral iron can benefit from this treatment. Venofer injection provides iron sucrose where iron is the intravenous (IV) form of iron. It is necessary for bone marrow as it helps to make new red blood cells and provide oxygen to organs and tissues via hemoglobin. Many new born children lose a large amount of blood during labor or delivery. They have breathing problems and if treatment is not proper at pediatric stage, they are prone to suffering from anemia. Many times doctors perform ultrasound tests to see if the baby has any signs of anemia. Today liquid drops medicines are available for pediatric patients suffering from iron deficiency anemia.
End Users Outlook:
Based on end user, this report from Absolute Markets Insights segments the global iron deficiency anemia treatment market into hospitals, ambulatory surgical centers, home care, and others. In 2020, hospital segment occupied larger market share. During the forecast period, the home care segment is anticipated to witness highest growth rate due to due to ease of accessibility of health supplements from multiple distribution channels.
Region Outlook:
In 2020, North America held the largest market share in the global iron deficiency anemia treatment market. During the forecast period, Asia Pacific region is estimated to register highest CAGR. The market growth in this region can be attributed to the highest anemic patient population which is primarily due to lack of awareness about anemia and less focus on healthy lifestyle in urban areas. Other factors contributing to the market growth in the Asia Pacific region include various government initiatives about anemia, increasing awareness regarding diagnosis & treatment, and continuous research & development in many Asian countries. According to a study, India had about 7.5 million people likely to be suffering from some form of anemia in 2016 and over the years, this number has only increased.
Competitive Landscape Outlook:
The global iron deficiency anemia treatment market landscape remains a highly innovative, competitive, and fragmented landscape. Despite major investments from many big players of medical sector enterprises, most companies do not have a sizable share of the market to influence pricing. Some key players in the global iron deficiency anemia treatment market are Acceleron Pharma Inc., Akebia Therapeutics Inc., Allergan, AMAG Pharmaceuticals Inc., American Regent Inc. (Venofer), Daiichi Sankyo Inc. (Injectafer), PHARMACOSMOS A/S, Pieris Pharmaceuticals Inc., Rockwell Medical Inc., Sanofi, and Torii Pharmaceutical Co. Ltd. amongst others.
Global Iron Deficiency Anemia Treatment Market Market:
- By Treatment Type
- Supplements & Medications/Antibiotics
- Blood Transfusion
- Intravenous (IV) Iron Therapy
- Others
- By Gender
- Male
- Female
- By Age Group
- Pediatric
- Adult
- Geriatric
- By End Users
- Hospitals
- Ambulatory Surgical Centers
- Home Care
- Others
- By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2019
1.2.2. Base
Year: 2020
1.2.3. Forecast
Years: 2021 – 2029
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Iron Deficiency Anemia Treatment Market
6. Market Synopsis: Iron
Deficiency Anemia Treatment Market
7. Iron Deficiency Anemia Treatment Market Analysis: Qualitative
Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Iron Deficiency Anemia Treatment Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Iron Deficiency Anemia Treatment Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on Iron Deficiency Anemia Treatment Market
8. Global Iron Deficiency Anemia Treatment Market Analysis and
Forecasts, 2021 – 2029
8.1. Overview
8.1.1. Global
Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
8.2. Global
Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts, By
Treatment Type
8.2.1. Supplements
and Medications/Antibiotics
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 – 2020
8.2.1.3. Market Forecast, 2021 – 2029
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market
Estimation, 2015 – 2020
8.2.1.5.1.2. Market
Forecast, 2021 – 2029
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 – 2020
8.2.1.5.2.2. Market
Forecast, 2021 – 2029
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market
Estimation, 2015 – 2020
8.2.1.5.3.2. Market
Forecast, 2021 – 2029
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 – 2020
8.2.1.5.4.2. Market
Forecast, 2021 – 2029
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market
Estimation, 2015 – 2020
8.2.1.5.5.2. Market
Forecast, 2021 – 2029
8.2.2. Blood
Transfusion
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 – 2020
8.2.2.3. Market Forecast, 2021 – 2029
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 – 2020
8.2.2.5.1.2. Market
Forecast, 2021 – 2029
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 – 2020
8.2.2.5.2.2. Market
Forecast, 2021 – 2029
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 – 2020
8.2.2.5.3.2. Market
Forecast, 2021 – 2029
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 – 2020
8.2.2.5.4.2. Market
Forecast, 2021 – 2029
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 – 2020
8.2.2.5.5.2. Market
Forecast, 2021 – 2029
8.2.3. Intravenous
(IV) Iron Therapy
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 – 2020
8.2.3.3. Market Forecast, 2021 – 2029
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market
Estimation, 2015 – 2020
8.2.3.5.1.2. Market
Forecast, 2021 – 2029
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 – 2020
8.2.3.5.2.2. Market
Forecast, 2021 – 2029
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market
Estimation, 2015 – 2020
8.2.3.5.3.2. Market
Forecast, 2021 – 2029
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 – 2020
8.2.3.5.4.2. Market
Forecast, 2021 – 2029
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market
Estimation, 2015 – 2020
8.2.3.5.5.2. Market
Forecast, 2021 – 2029
8.2.4. Others
8.2.4.1. Definition
8.2.4.2. Market Estimation and Penetration, 2015 – 2020
8.2.4.3. Market Forecast, 2021 – 2029
8.2.4.4. Compound Annual Growth Rate (CAGR)
8.2.4.5. Regional Bifurcation
8.2.4.5.1. North America
8.2.4.5.1.1. Market
Estimation, 2015 – 2020
8.2.4.5.1.2. Market
Forecast, 2021 – 2029
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 – 2020
8.2.4.5.2.2. Market
Forecast, 2021 – 2029
8.2.4.5.3. Asia Pacific
8.2.4.5.3.1. Market
Estimation, 2015 – 2020
8.2.4.5.3.2. Market
Forecast, 2021 – 2029
8.2.4.5.4. Middle East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 – 2020
8.2.4.5.4.2. Market
Forecast, 2021 – 2029
8.2.4.5.5. Latin America
8.2.4.5.5.1. Market
Estimation, 2015 – 2020
8.2.4.5.5.2. Market
Forecast, 2021 – 2029
8.3. Key
Segment for Channeling Investments
8.3.1. By
Treatment Type
9. Global Iron Deficiency Anemia Treatment Market Analysis and
Forecasts, 2021 – 2029
9.1. Overview
9.2. Global
Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts, By
Gender
9.2.1. Male
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 – 2020
9.2.1.3. Market Forecast, 2021 – 2029
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 – 2020
9.2.1.5.1.2. Market
Forecast, 2021 – 2029
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 – 2020
9.2.1.5.2.2. Market
Forecast, 2021 – 2029
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 – 2020
9.2.1.5.3.2. Market
Forecast, 2021 – 2029
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 – 2020
9.2.1.5.4.2. Market
Forecast, 2021 – 2029
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 – 2020
9.2.1.5.5.2. Market
Forecast, 2021 – 2029
9.2.2. Female
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 – 2020
9.2.2.3. Market Forecast, 2021 – 2029
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 – 2020
9.2.2.5.1.2. Market
Forecast, 2021 – 2029
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 – 2020
9.2.2.5.2.2. Market
Forecast, 2021 – 2029
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 – 2020
9.2.2.5.3.2. Market
Forecast, 2021 – 2029
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 – 2020
9.2.2.5.4.2. Market
Forecast, 2021 – 2029
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 – 2020
9.2.2.5.5.2. Market
Forecast, 2021 – 2029
9.3. Key
Segment for Channeling Investments
9.3.1. By
Gender
10. Global Iron Deficiency Anemia Treatment Market Analysis and
Forecasts, 2021 – 2029
10.1. Overview
10.2. Global
Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts, By Age
Group
10.2.1. Pediatric
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 – 2020
10.2.1.3. Market Forecast, 2021 – 2029
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 – 2020
10.2.1.5.1.2. Market
Forecast, 2021 – 2029
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 – 2020
10.2.1.5.2.2. Market
Forecast, 2021 – 2029
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 – 2020
10.2.1.5.3.2. Market
Forecast, 2021 – 2029
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 – 2020
10.2.1.5.4.2. Market
Forecast, 2021 – 2029
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 – 2020
10.2.1.5.5.2. Market
Forecast, 2021 – 2029
10.2.2. Adult
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 – 2020
10.2.2.3. Market Forecast, 2021 – 2029
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 – 2020
10.2.2.5.1.2. Market
Forecast, 2021 – 2029
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 – 2020
10.2.2.5.2.2. Market
Forecast, 2021 – 2029
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 – 2020
10.2.2.5.3.2. Market
Forecast, 2021 – 2029
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 – 2020
10.2.2.5.4.2. Market
Forecast, 2021 – 2029
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 – 2020
10.2.2.5.5.2. Market
Forecast, 2021 – 2029
10.2.3. Geriatric
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 – 2020
10.2.3.3. Market Forecast, 2021 – 2029
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2015 – 2020
10.2.3.5.1.2. Market
Forecast, 2021 – 2029
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 – 2020
10.2.3.5.2.2. Market
Forecast, 2021 – 2029
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2015 – 2020
10.2.3.5.3.2. Market
Forecast, 2021 – 2029
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 – 2020
10.2.3.5.4.2. Market
Forecast, 2021 – 2029
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2015 – 2020
10.2.3.5.5.2. Market
Forecast, 2021 – 2029
10.3. Key
Segment for Channeling Investments
10.3.1. By Age
Group
11. Global Iron Deficiency Anemia Treatment Market Analysis and
Forecasts, 2021 – 2029
11.1. Overview
11.2. Global
Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts, By End
Users
11.2.1. Hospitals
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 – 2020
11.2.1.3. Market Forecast, 2021 – 2029
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2015 – 2020
11.2.1.5.1.2. Market
Forecast, 2021 – 2029
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 – 2020
11.2.1.5.2.2. Market
Forecast, 2021 – 2029
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2015 – 2020
11.2.1.5.3.2. Market
Forecast, 2021 – 2029
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 – 2020
11.2.1.5.4.2. Market
Forecast, 2021 – 2029
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2015 – 2020
11.2.1.5.5.2. Market
Forecast, 2021 – 2029
11.2.2. Ambulatory
Surgical Centers
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 – 2020
11.2.2.3. Market Forecast, 2021 – 2029
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2015 – 2020
11.2.2.5.1.2. Market
Forecast, 2021 – 2029
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 – 2020
11.2.2.5.2.2. Market
Forecast, 2021 – 2029
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2015 – 2020
11.2.2.5.3.2. Market
Forecast, 2021 – 2029
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 – 2020
11.2.2.5.4.2. Market
Forecast, 2021 – 2029
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2015 – 2020
11.2.2.5.5.2. Market
Forecast, 2021 – 2029
11.2.3. Home
Care
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 – 2020
11.2.3.3. Market Forecast, 2021 – 2029
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market
Estimation, 2015 – 2020
11.2.3.5.1.2. Market
Forecast, 2021 – 2029
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 – 2020
11.2.3.5.2.2. Market
Forecast, 2021 – 2029
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market
Estimation, 2015 – 2020
11.2.3.5.3.2. Market
Forecast, 2021 – 2029
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 – 2020
11.2.3.5.4.2. Market
Forecast, 2021 – 2029
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market
Estimation, 2015 – 2020
11.2.3.5.5.2. Market
Forecast, 2021 – 2029
11.2.4. Others
11.2.4.1. Definition
11.2.4.2. Market Estimation and Penetration, 2015 – 2020
11.2.4.3. Market Forecast, 2021 – 2029
11.2.4.4. Compound Annual Growth Rate (CAGR)
11.2.4.5. Regional Bifurcation
11.2.4.5.1. North America
11.2.4.5.1.1. Market
Estimation, 2015 – 2020
11.2.4.5.1.2. Market
Forecast, 2021 – 2029
11.2.4.5.2. Europe
11.2.4.5.2.1. Market
Estimation, 2015 – 2020
11.2.4.5.2.2. Market
Forecast, 2021 – 2029
11.2.4.5.3. Asia Pacific
11.2.4.5.3.1. Market
Estimation, 2015 – 2020
11.2.4.5.3.2. Market
Forecast, 2021 – 2029
11.2.4.5.4. Middle East and Africa
11.2.4.5.4.1. Market
Estimation, 2015 – 2020
11.2.4.5.4.2. Market
Forecast, 2021 – 2029
11.2.4.5.5. Latin America
11.2.4.5.5.1. Market
Estimation, 2015 – 2020
11.2.4.5.5.2. Market
Forecast, 2021 – 2029
11.3. Key
Segment for Channeling Investments
11.3.1. By End
Users
12. North America Iron Deficiency Anemia Treatment Market Analysis
and Forecasts, 2020 - 2028
12.1. Overview
12.1.1. North
America Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
12.2. North
America Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts,
By Treatment Type
12.2.1. Supplements
and Medications/Antibiotics
12.2.2. Blood
Transfusion
12.2.3. Intravenous
(IV) Iron Therapy
12.2.4. Others
12.3. North
America Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts,
By Gender
12.3.1. Male
12.3.2. Female
12.4. North
America Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts,
By Age Group
12.4.1. Pediatric
12.4.2. Adult
12.4.3. Geriatric
12.5. North
America Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts,
By End Users
12.5.1. Hospitals
12.5.2. Ambulatory
Surgical Centers
12.5.3. Home
Care
12.5.4. Others
12.6. North
America Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts,
By Country
12.6.1. U.S
12.6.1.1. U.S Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Treatment Type
12.6.1.1.1. Supplements and Medications/Antibiotics
12.6.1.1.2. Blood Transfusion
12.6.1.1.3. Intravenous (IV) Iron Therapy
12.6.1.1.4. Others
12.6.1.2. U.S Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Gender
12.6.1.2.1. Male
12.6.1.2.2. Female
12.6.1.3. U.S Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Age Group
12.6.1.3.1. Pediatric
12.6.1.3.2. Adult
12.6.1.3.3. Geriatric
12.6.1.4. U.S Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By End Users
12.6.1.4.1. Hospitals
12.6.1.4.2. Ambulatory Surgical Centers
12.6.1.4.3. Home Care
12.6.1.4.4. Others
12.6.2. Canada
12.6.2.1. Canada Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Treatment Type
12.6.2.1.1. Supplements and Medications/Antibiotics
12.6.2.1.2. Blood Transfusion
12.6.2.1.3. Intravenous (IV) Iron Therapy
12.6.2.1.4. Others
12.6.2.2. Canada Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Gender
12.6.2.2.1. Male
12.6.2.2.2. Female
12.6.2.3. Canada Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Age Group
12.6.2.3.1. Pediatric
12.6.2.3.2. Adult
12.6.2.3.3. Geriatric
12.6.2.4. Canada Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By End Users
12.6.2.4.1. Hospitals
12.6.2.4.2. Ambulatory Surgical Centers
12.6.2.4.3. Home Care
12.6.2.4.4. Others
12.6.3. Mexico
12.6.3.1. Mexico Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Treatment Type
12.6.3.1.1. Supplements and Medications/Antibiotics
12.6.3.1.2. Blood Transfusion
12.6.3.1.3. Intravenous (IV) Iron Therapy
12.6.3.1.4. Others
12.6.3.2. Mexico Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Gender
12.6.3.2.1. Male
12.6.3.2.2. Female
12.6.3.3. Mexico Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Age Group
12.6.3.3.1. Pediatric
12.6.3.3.2. Adult
12.6.3.3.3. Geriatric
12.6.3.4. Mexico Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By End Users
12.6.3.4.1. Hospitals
12.6.3.4.2. Ambulatory Surgical Centers
12.6.3.4.3. Home Care
12.6.3.4.4. Others
12.6.4. Rest of
North America
12.6.4.1. Rest of North America Iron Deficiency Anemia Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
12.6.4.1.1. Supplements and Medications/Antibiotics
12.6.4.1.2. Blood Transfusion
12.6.4.1.3. Intravenous (IV) Iron Therapy
12.6.4.1.4. Others
12.6.4.2. Rest of North America Iron Deficiency Anemia Treatment Market
Revenue (US$ Mn) and Forecasts, By Gender
12.6.4.2.1. Male
12.6.4.2.2. Female
12.6.4.3. Rest of North America Iron Deficiency Anemia Treatment Market
Revenue (US$ Mn) and Forecasts, By Age Group
12.6.4.3.1. Pediatric
12.6.4.3.2. Adult
12.6.4.3.3. Geriatric
12.6.4.4. Rest of North America Iron Deficiency Anemia Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
12.6.4.4.1. Hospitals
12.6.4.4.2. Ambulatory Surgical Centers
12.6.4.4.3. Home Care
12.6.4.4.4. Others
12.7. Key
Segment for Channeling Investments
12.7.1. By
Country
12.7.2. By
Treatment Type
12.7.3. By
Gender
12.7.4. By Age
Group
12.7.5. By End
Users
13. Europe Iron Deficiency Anemia Treatment Market Analysis and
Forecasts, 2020 - 2028
13.1. Overview
13.1.1. Europe
Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
13.2. Europe
Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts, By
Treatment Type
13.2.1. Supplements
and Medications/Antibiotics
13.2.2. Blood
Transfusion
13.2.3. Intravenous
(IV) Iron Therapy
13.2.4. Others
13.3. Europe
Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts, By
Gender
13.3.1. Male
13.3.2. Female
13.4. Europe
Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts, By Age
Group
13.4.1. Pediatric
13.4.2. Adult
13.4.3. Geriatric
13.5. Europe
Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts, By End
Users
13.5.1. Hospitals
13.5.2. Ambulatory
Surgical Centers
13.5.3. Home
Care
13.5.4. Others
13.6. Europe
Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts, By
Country
13.6.1. France
13.6.1.1. France Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Treatment Type
13.6.1.1.1. Supplements and Medications/Antibiotics
13.6.1.1.2. Blood Transfusion
13.6.1.1.3. Intravenous (IV) Iron Therapy
13.6.1.1.4. Others
13.6.1.2. France Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Gender
13.6.1.2.1. Male
13.6.1.2.2. Female
13.6.1.3. France Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Age Group
13.6.1.3.1. Pediatric
13.6.1.3.2. Adult
13.6.1.3.3. Geriatric
13.6.1.4. France Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By End Users
13.6.1.4.1. Hospitals
13.6.1.4.2. Ambulatory Surgical Centers
13.6.1.4.3. Home Care
13.6.1.4.4. Others
13.6.2. The UK
13.6.2.1. The UK Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Treatment Type
13.6.2.1.1. Supplements and Medications/Antibiotics
13.6.2.1.2. Blood Transfusion
13.6.2.1.3. Intravenous (IV) Iron Therapy
13.6.2.1.4. Others
13.6.2.2. The UK Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Gender
13.6.2.2.1. Male
13.6.2.2.2. Female
13.6.2.3. The UK Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Age Group
13.6.2.3.1. Pediatric
13.6.2.3.2. Adult
13.6.2.3.3. Geriatric
13.6.2.4. The UK Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By End Users
13.6.2.4.1. Hospitals
13.6.2.4.2. Ambulatory Surgical Centers
13.6.2.4.3. Home Care
13.6.2.4.4. Others
13.6.3. Spain
13.6.3.1. Spain Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Treatment Type
13.6.3.1.1. Supplements and Medications/Antibiotics
13.6.3.1.2. Blood Transfusion
13.6.3.1.3. Intravenous (IV) Iron Therapy
13.6.3.1.4. Others
13.6.3.2. Spain Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Gender
13.6.3.2.1. Male
13.6.3.2.2. Female
13.6.3.3. Spain Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Age Group
13.6.3.3.1. Pediatric
13.6.3.3.2. Adult
13.6.3.3.3. Geriatric
13.6.3.4. Spain Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By End Users
13.6.3.4.1. Hospitals
13.6.3.4.2. Ambulatory Surgical Centers
13.6.3.4.3. Home Care
13.6.3.4.4. Others
13.6.4. Germany
13.6.4.1. Germany Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Treatment Type
13.6.4.1.1. Supplements and Medications/Antibiotics
13.6.4.1.2. Blood Transfusion
13.6.4.1.3. Intravenous (IV) Iron Therapy
13.6.4.1.4. Others
13.6.4.2. Germany Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Gender
13.6.4.2.1. Male
13.6.4.2.2. Female
13.6.4.3. Germany Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Age Group
13.6.4.3.1. Pediatric
13.6.4.3.2. Adult
13.6.4.3.3. Geriatric
13.6.4.4. Germany Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By End Users
13.6.4.4.1. Hospitals
13.6.4.4.2. Ambulatory Surgical Centers
13.6.4.4.3. Home Care
13.6.4.4.4. Others
13.6.5. Italy
13.6.5.1. Italy Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Treatment Type
13.6.5.1.1. Supplements and Medications/Antibiotics
13.6.5.1.2. Blood Transfusion
13.6.5.1.3. Intravenous (IV) Iron Therapy
13.6.5.1.4. Others
13.6.5.2. Italy Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Gender
13.6.5.2.1. Male
13.6.5.2.2. Female
13.6.5.3. Italy Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Age Group
13.6.5.3.1. Pediatric
13.6.5.3.2. Adult
13.6.5.3.3. Geriatric
13.6.5.4. Italy Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By End Users
13.6.5.4.1. Hospitals
13.6.5.4.2. Ambulatory Surgical Centers
13.6.5.4.3. Home Care
13.6.5.4.4. Others
13.6.6. Nordic
Countries
13.6.6.1. Nordic Countries Iron Deficiency Anemia Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
13.6.6.1.1. Supplements and Medications/Antibiotics
13.6.6.1.2. Blood Transfusion
13.6.6.1.3. Intravenous (IV) Iron Therapy
13.6.6.1.4. Others
13.6.6.2. Nordic Countries Iron Deficiency Anemia Treatment Market
Revenue (US$ Mn) and Forecasts, By Gender
13.6.6.2.1. Male
13.6.6.2.2. Female
13.6.6.3. Nordic Countries Iron Deficiency Anemia Treatment Market
Revenue (US$ Mn) and Forecasts, By Age Group
13.6.6.3.1. Pediatric
13.6.6.3.2. Adult
13.6.6.3.3. Geriatric
13.6.6.4. Nordic Countries Iron Deficiency Anemia Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
13.6.6.4.1. Hospitals
13.6.6.4.2. Ambulatory Surgical Centers
13.6.6.4.3. Home Care
13.6.6.4.4. Others
13.6.6.5. Nordic Countries Iron Deficiency Anemia Treatment Market
Revenue (US$ Mn) and Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux
Union
13.6.7.1. Benelux Union Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Treatment Type
13.6.7.1.1. Supplements and Medications/Antibiotics
13.6.7.1.2. Blood Transfusion
13.6.7.1.3. Intravenous (IV) Iron Therapy
13.6.7.1.4. Others
13.6.7.2. Benelux Union Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Gender
13.6.7.2.1. Male
13.6.7.2.2. Female
13.6.7.3. Benelux Union Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Age Group
13.6.7.3.1. Pediatric
13.6.7.3.2. Adult
13.6.7.3.3. Geriatric
13.6.7.4. Benelux Union Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By End Users
13.6.7.4.1. Hospitals
13.6.7.4.2. Ambulatory Surgical Centers
13.6.7.4.3. Home Care
13.6.7.4.4. Others
13.6.7.5. Benelux Union Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of
Europe
13.6.8.1. Rest of Europe Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Treatment Type
13.6.8.1.1. Supplements and Medications/Antibiotics
13.6.8.1.2. Blood Transfusion
13.6.8.1.3. Intravenous (IV) Iron Therapy
13.6.8.1.4. Others
13.6.8.2. Rest of Europe Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Gender
13.6.8.2.1. Male
13.6.8.2.2. Female
13.6.8.3. Rest of Europe Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Age Group
13.6.8.3.1. Pediatric
13.6.8.3.2. Adult
13.6.8.3.3. Geriatric
13.6.8.4. Rest of Europe Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By End Users
13.6.8.4.1. Hospitals
13.6.8.4.2. Ambulatory Surgical Centers
13.6.8.4.3. Home Care
13.6.8.4.4. Others
13.7. Key
Segment for Channeling Investments
13.7.1. By
Country
13.7.2. By
Treatment Type
13.7.3. By
Gender
13.7.4. By Age
Group
13.7.5. By End
Users
14. Asia Pacific Iron Deficiency Anemia Treatment Market Analysis
and Forecasts, 2020 - 2028
14.1. Overview
14.1.1. Asia
Pacific Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
14.2. Asia
Pacific Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts,
By Treatment Type
14.2.1. Supplements
and Medications/Antibiotics
14.2.2. Blood
Transfusion
14.2.3. Intravenous
(IV) Iron Therapy
14.2.4. Others
14.3. Asia
Pacific Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts,
By Gender
14.3.1. Male
14.3.2. Female
14.4. Asia
Pacific Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts,
By Age Group
14.4.1. Pediatric
14.4.2. Adult
14.4.3. Geriatric
14.5. Asia
Pacific Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts,
By End Users
14.5.1. Hospitals
14.5.2. Ambulatory
Surgical Centers
14.5.3. Home
Care
14.5.4. Others
14.6. Asia
Pacific Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts,
By Country
14.6.1. China
14.6.1.1. China Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Treatment Type
14.6.1.1.1. Supplements and Medications/Antibiotics
14.6.1.1.2. Blood Transfusion
14.6.1.1.3. Intravenous (IV) Iron Therapy
14.6.1.1.4. Others
14.6.1.2. China Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Gender
14.6.1.2.1. Male
14.6.1.2.2. Female
14.6.1.3. China Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Age Group
14.6.1.3.1. Pediatric
14.6.1.3.2. Adult
14.6.1.3.3. Geriatric
14.6.1.4. China Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By End Users
14.6.1.4.1. Hospitals
14.6.1.4.2. Ambulatory Surgical Centers
14.6.1.4.3. Home Care
14.6.1.4.4. Others
14.6.2. Japan
14.6.2.1. Japan Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Treatment Type
14.6.2.1.1. Supplements and Medications/Antibiotics
14.6.2.1.2. Blood Transfusion
14.6.2.1.3. Intravenous (IV) Iron Therapy
14.6.2.1.4. Others
14.6.2.2. Japan Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Gender
14.6.2.2.1. Male
14.6.2.2.2. Female
14.6.2.3. Japan Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Age Group
14.6.2.3.1. Pediatric
14.6.2.3.2. Adult
14.6.2.3.3. Geriatric
14.6.2.4. Japan Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By End Users
14.6.2.4.1. Hospitals
14.6.2.4.2. Ambulatory Surgical Centers
14.6.2.4.3. Home Care
14.6.2.4.4. Others
14.6.3. India
14.6.3.1. India Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Treatment Type
14.6.3.1.1. Supplements and Medications/Antibiotics
14.6.3.1.2. Blood Transfusion
14.6.3.1.3. Intravenous (IV) Iron Therapy
14.6.3.1.4. Others
14.6.3.2. India Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Gender
14.6.3.2.1. Male
14.6.3.2.2. Female
14.6.3.3. India Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Age Group
14.6.3.3.1. Pediatric
14.6.3.3.2. Adult
14.6.3.3.3. Geriatric
14.6.3.4. India Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By End Users
14.6.3.4.1. Hospitals
14.6.3.4.2. Ambulatory Surgical Centers
14.6.3.4.3. Home Care
14.6.3.4.4. Others
14.6.4. New
Zealand
14.6.4.1. New Zealand Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Treatment Type
14.6.4.1.1. Supplements and Medications/Antibiotics
14.6.4.1.2. Blood Transfusion
14.6.4.1.3. Intravenous (IV) Iron Therapy
14.6.4.1.4. Others
14.6.4.2. New Zealand Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Gender
14.6.4.2.1. Male
14.6.4.2.2. Female
14.6.4.3. New Zealand Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Age Group
14.6.4.3.1. Pediatric
14.6.4.3.2. Adult
14.6.4.3.3. Geriatric
14.6.4.4. New Zealand Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By End Users
14.6.4.4.1. Hospitals
14.6.4.4.2. Ambulatory Surgical Centers
14.6.4.4.3. Home Care
14.6.4.4.4. Others
14.6.5. Australia
14.6.5.1. Australia Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Treatment Type
14.6.5.1.1. Supplements and Medications/Antibiotics
14.6.5.1.2. Blood Transfusion
14.6.5.1.3. Intravenous (IV) Iron Therapy
14.6.5.1.4. Others
14.6.5.2. Australia Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Gender
14.6.5.2.1. Male
14.6.5.2.2. Female
14.6.5.3. Australia Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Age Group
14.6.5.3.1. Pediatric
14.6.5.3.2. Adult
14.6.5.3.3. Geriatric
14.6.5.4. Australia Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By End Users
14.6.5.4.1. Hospitals
14.6.5.4.2. Ambulatory Surgical Centers
14.6.5.4.3. Home Care
14.6.5.4.4. Others
14.6.6. South
Korea
14.6.6.1. South Korea Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Treatment Type
14.6.6.1.1. Supplements and Medications/Antibiotics
14.6.6.1.2. Blood Transfusion
14.6.6.1.3. Intravenous (IV) Iron Therapy
14.6.6.1.4. Others
14.6.6.2. South Korea Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Gender
14.6.6.2.1. Male
14.6.6.2.2. Female
14.6.6.3. South Korea Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Age Group
14.6.6.3.1. Pediatric
14.6.6.3.2. Adult
14.6.6.3.3. Geriatric
14.6.6.4. South Korea Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By End Users
14.6.6.4.1. Hospitals
14.6.6.4.2. Ambulatory Surgical Centers
14.6.6.4.3. Home Care
14.6.6.4.4. Others
14.6.7. Southeast
Asia
14.6.7.1. Southeast Asia Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Treatment Type
14.6.7.1.1. Supplements and Medications/Antibiotics
14.6.7.1.2. Blood Transfusion
14.6.7.1.3. Intravenous (IV) Iron Therapy
14.6.7.1.4. Others
14.6.7.2. Southeast Asia Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Gender
14.6.7.2.1. Male
14.6.7.2.2. Female
14.6.7.3. Southeast Asia Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Age Group
14.6.7.3.1. Pediatric
14.6.7.3.2. Adult
14.6.7.3.3. Geriatric
14.6.7.4. Southeast Asia Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By End Users
14.6.7.4.1. Hospitals
14.6.7.4.2. Ambulatory Surgical Centers
14.6.7.4.3. Home Care
14.6.7.4.4. Others
14.6.7.5. Southeast Asia Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8. Rest of
Asia Pacific
14.6.8.1. Rest of Asia Pacific Iron Deficiency Anemia Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
14.6.8.1.1. Supplements and Medications/Antibiotics
14.6.8.1.2. Blood Transfusion
14.6.8.1.3. Intravenous (IV) Iron Therapy
14.6.8.1.4. Others
14.6.8.2. Rest of Asia Pacific Iron Deficiency Anemia Treatment Market
Revenue (US$ Mn) and Forecasts, By Gender
14.6.8.2.1. Male
14.6.8.2.2. Female
14.6.8.3. Rest of Asia Pacific Iron Deficiency Anemia Treatment Market
Revenue (US$ Mn) and Forecasts, By Age Group
14.6.8.3.1. Pediatric
14.6.8.3.2. Adult
14.6.8.3.3. Geriatric
14.6.8.4. Rest of Asia Pacific Iron Deficiency Anemia Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
14.6.8.4.1. Hospitals
14.6.8.4.2. Ambulatory Surgical Centers
14.6.8.4.3. Home Care
14.6.8.4.4. Others
14.7. Key
Segment for Channeling Investments
14.7.1. By
Country
14.7.2. By
Treatment Type
14.7.3. By
Gender
14.7.4. By Age
Group
14.7.5. By End
Users
15. Middle East and Africa Iron Deficiency Anemia Treatment
Market Analysis and Forecasts, 2020 - 2028
15.1. Overview
15.1.1. Middle
East and Africa Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
15.2. Middle
East and Africa Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and
Forecasts, By Treatment Type
15.2.1. Supplements
and Medications/Antibiotics
15.2.2. Blood
Transfusion
15.2.3. Intravenous
(IV) Iron Therapy
15.2.4. Others
15.3. Middle
East and Africa Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and
Forecasts, By Gender
15.3.1. Male
15.3.2. Female
15.4. Middle
East and Africa Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and
Forecasts, By Age Group
15.4.1. Pediatric
15.4.2. Adult
15.4.3. Geriatric
15.5. Middle
East and Africa Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and
Forecasts, By End Users
15.5.1. Hospitals
15.5.2. Ambulatory
Surgical Centers
15.5.3. Home
Care
15.5.4. Others
15.6. Middle
East and Africa Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and
Forecasts, By Country
15.6.1. Saudi
Arabia
15.6.1.1. Saudi Arabia Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Treatment Type
15.6.1.1.1. Supplements and Medications/Antibiotics
15.6.1.1.2. Blood Transfusion
15.6.1.1.3. Intravenous (IV) Iron Therapy
15.6.1.1.4. Others
15.6.1.2. Saudi Arabia Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Gender
15.6.1.2.1. Male
15.6.1.2.2. Female
15.6.1.3. Saudi Arabia Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Age Group
15.6.1.3.1. Pediatric
15.6.1.3.2. Adult
15.6.1.3.3. Geriatric
15.6.1.4. Saudi Arabia Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By End Users
15.6.1.4.1. Hospitals
15.6.1.4.2. Ambulatory Surgical Centers
15.6.1.4.3. Home Care
15.6.1.4.4. Others
15.6.2. UAE
15.6.2.1. UAE Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Treatment Type
15.6.2.1.1. Supplements and Medications/Antibiotics
15.6.2.1.2. Blood Transfusion
15.6.2.1.3. Intravenous (IV) Iron Therapy
15.6.2.1.4. Others
15.6.2.2. UAE Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Gender
15.6.2.2.1. Male
15.6.2.2.2. Female
15.6.2.3. UAE Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Age Group
15.6.2.3.1. Pediatric
15.6.2.3.2. Adult
15.6.2.3.3. Geriatric
15.6.2.4. UAE Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By End Users
15.6.2.4.1. Hospitals
15.6.2.4.2. Ambulatory Surgical Centers
15.6.2.4.3. Home Care
15.6.2.4.4. Others
15.6.3. Egypt
15.6.3.1. Egypt Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Treatment Type
15.6.3.1.1. Supplements and Medications/Antibiotics
15.6.3.1.2. Blood Transfusion
15.6.3.1.3. Intravenous (IV) Iron Therapy
15.6.3.1.4. Others
15.6.3.2. Egypt Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Gender
15.6.3.2.1. Male
15.6.3.2.2. Female
15.6.3.3. Egypt Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By Age Group
15.6.3.3.1. Pediatric
15.6.3.3.2. Adult
15.6.3.3.3. Geriatric
15.6.3.4. Egypt Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
and Forecasts, By End Users
15.6.3.4.1. Hospitals
15.6.3.4.2. Ambulatory Surgical Centers
15.6.3.4.3. Home Care
15.6.3.4.4. Others
15.6.4. Kuwait
15.6.4.1. Kuwait Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Treatment Type
15.6.4.1.1. Supplements and Medications/Antibiotics
15.6.4.1.2. Blood Transfusion
15.6.4.1.3. Intravenous (IV) Iron Therapy
15.6.4.1.4. Others
15.6.4.2. Kuwait Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Gender
15.6.4.2.1. Male
15.6.4.2.2. Female
15.6.4.3. Kuwait Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Age Group
15.6.4.3.1. Pediatric
15.6.4.3.2. Adult
15.6.4.3.3. Geriatric
15.6.4.4. Kuwait Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By End Users
15.6.4.4.1. Hospitals
15.6.4.4.2. Ambulatory Surgical Centers
15.6.4.4.3. Home Care
15.6.4.4.4. Others
15.6.5. South
Africa
15.6.5.1. South Africa Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Treatment Type
15.6.5.1.1. Supplements and Medications/Antibiotics
15.6.5.1.2. Blood Transfusion
15.6.5.1.3. Intravenous (IV) Iron Therapy
15.6.5.1.4. Others
15.6.5.2. South Africa Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Gender
15.6.5.2.1. Male
15.6.5.2.2. Female
15.6.5.3. South Africa Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By Age Group
15.6.5.3.1. Pediatric
15.6.5.3.2. Adult
15.6.5.3.3. Geriatric
15.6.5.4. South Africa Iron Deficiency Anemia Treatment Market Revenue
(US$ Mn) and Forecasts, By End Users
15.6.5.4.1. Hospitals
15.6.5.4.2. Ambulatory Surgical Centers
15.6.5.4.3. Home Care
15.6.5.4.4. Others
15.6.6. Rest of
Middle East & Africa
15.6.6.1. Rest of Middle East & Africa Iron Deficiency Anemia
Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Type
15.6.6.1.1. Supplements and Medications/Antibiotics
15.6.6.1.2. Blood Transfusion
15.6.6.1.3. Intravenous (IV) Iron Therapy
15.6.6.1.4. Others
15.6.6.2. Rest of Middle East & Africa Iron Deficiency Anemia
Treatment Market Revenue (US$ Mn) and Forecasts, By Gender
15.6.6.2.1. Male
15.6.6.2.2. Female
15.6.6.3. Rest of Middle East & Africa Iron Deficiency Anemia
Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group
15.6.6.3.1. Pediatric
15.6.6.3.2. Adult
15.6.6.3.3. Geriatric
15.6.6.4. Rest of Middle East & Africa Iron Deficiency Anemia
Treatment Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.6.4.1. Hospitals
15.6.6.4.2. Ambulatory Surgical Centers
15.6.6.4.3. Home Care
15.6.6.4.4. Others
15.7. Key
Segment for Channeling Investments
15.7.1. By
Country
15.7.2. By
Treatment Type
15.7.3. By
Gender
15.7.4. By Age
Group
15.7.5. By End
Users
16. Latin America Iron Deficiency Anemia Treatment Market
Analysis and Forecasts, 2020 - 2028
16.1. Overview
16.1.1. Latin
America Iron Deficiency Anemia Treatment Market Revenue (US$ Mn)
16.2. Latin
America Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts,
By Treatment Type
16.2.1. Supplements
and Medications/Antibiotics
16.2.2. Blood
Transfusion
16.2.3. Intravenous
(IV) Iron Therapy
16.2.4. Others
16.3. Latin
America Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts,
By Gender
16.3.1. Male
16.3.2. Female
16.4. Latin
America Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts,
By Age Group
16.4.1. Pediatric
16.4.2. Adult
16.4.3. Geriatric
16.5. Latin
America Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts,
By End Users
16.5.1. Hospitals
16.5.2. Ambulatory
Surgical Centers
16.5.3. Home
Care
16.5.4. Others
16.6. Latin
America Iron Deficiency Anemia Treatment Market Revenue (US$ Mn) and Forecasts,
By Country
16.6.1. Brazil
16.6.1.1. Brazil Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Treatment Type
16.6.1.1.1. Supplements and Medications/Antibiotics
16.6.1.1.2. Blood Transfusion
16.6.1.1.3. Intravenous (IV) Iron Therapy
16.6.1.1.4. Others
16.6.1.2. Brazil Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Gender
16.6.1.2.1. Male
16.6.1.2.2. Female
16.6.1.3. Brazil Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Age Group
16.6.1.3.1. Pediatric
16.6.1.3.2. Adult
16.6.1.3.3. Geriatric
16.6.1.4. Brazil Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By End Users
16.6.1.4.1. Hospitals
16.6.1.4.2. Ambulatory Surgical Centers
16.6.1.4.3. Home Care
16.6.1.4.4. Others
16.6.2. Argentina
16.6.2.1. Argentina Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Treatment Type
16.6.2.1.1. Supplements and Medications/Antibiotics
16.6.2.1.2. Blood Transfusion
16.6.2.1.3. Intravenous (IV) Iron Therapy
16.6.2.1.4. Others
16.6.2.2. Argentina Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Gender
16.6.2.2.1. Male
16.6.2.2.2. Female
16.6.2.3. Argentina Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By Age Group
16.6.2.3.1. Pediatric
16.6.2.3.2. Adult
16.6.2.3.3. Geriatric
16.6.2.4. Argentina Iron Deficiency Anemia Treatment Market Revenue (US$
Mn) and Forecasts, By End Users
16.6.2.4.1. Hospitals
16.6.2.4.2. Ambulatory Surgical Centers
16.6.2.4.3. Home Care
16.6.2.4.4. Others
16.6.3. Rest of
Latin America
16.6.3.1. Rest of Latin America Iron Deficiency Anemia Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
16.6.3.1.1. Supplements and Medications/Antibiotics
16.6.3.1.2. Blood Transfusion
16.6.3.1.3. Intravenous (IV) Iron Therapy
16.6.3.1.4. Others
16.6.3.2. Rest of Latin America Iron Deficiency Anemia Treatment Market
Revenue (US$ Mn) and Forecasts, By Gender
16.6.3.2.1. Male
16.6.3.2.2. Female
16.6.3.3. Rest of Latin America Iron Deficiency Anemia Treatment Market
Revenue (US$ Mn) and Forecasts, By Age Group
16.6.3.3.1. Pediatric
16.6.3.3.2. Adult
16.6.3.3.3. Geriatric
16.6.3.4. Rest of Latin America Iron Deficiency Anemia Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
16.6.3.4.1. Hospitals
16.6.3.4.2. Ambulatory Surgical Centers
16.6.3.4.3. Home Care
16.6.3.4.4. Others
16.7. Key
Segment for Channeling Investments
16.7.1. By
Country
16.7.2. By
Treatment Type
16.7.3. By
Gender
16.7.4. By Age Group
16.7.5. By End
Users
17. Competitive Benchmarking
17.1. Market
Share Analysis, 2019
17.2. Global
Presence and Growth Strategies
17.2.1. Mergers
and Acquisitions
17.2.2. Product
Launches
17.2.3. Investments
Trends
17.2.4. R&D
Initiatives
18. Player Profiles
18.1. Acceleron
Pharma, Inc.
18.1.1. Company
Details
18.1.2. Company
Overview
18.1.3. Product
Offerings
18.1.4. Key
Developments
18.1.5. Financial
Analysis
18.1.6. SWOT
Analysis
18.1.7. Business
Strategies
18.2. Akebia
Therapeutics, Inc.
18.2.1. Company
Details
18.2.2. Company
Overview
18.2.3. Product
Offerings
18.2.4. Key
Developments
18.2.5. Financial
Analysis
18.2.6. SWOT
Analysis
18.2.7. Business
Strategies
18.3. Allergan
18.3.1. Company
Details
18.3.2. Company
Overview
18.3.3. Product
Offerings
18.3.4. Key
Developments
18.3.5. Financial
Analysis
18.3.6. SWOT
Analysis
18.3.7. Business
Strategies
18.4. AMAG
Pharmaceuticals, Inc.
18.4.1. Company
Details
18.4.2. Company
Overview
18.4.3. Product
Offerings
18.4.4. Key
Developments
18.4.5. Financial
Analysis
18.4.6. SWOT
Analysis
18.4.7. Business
Strategies
18.5. American
Regent, Inc. (Venofer)
18.5.1. Company
Details
18.5.2. Company
Overview
18.5.3. Product
Offerings
18.5.4. Key
Developments
18.5.5. Financial
Analysis
18.5.6. SWOT
Analysis
18.5.7. Business
Strategies
18.6. Daiichi
Sankyo, Inc. (Injectafer)
18.6.1. Company
Details
18.6.2. Company
Overview
18.6.3. Product
Offerings
18.6.4. Key
Developments
18.6.5. Financial
Analysis
18.6.6. SWOT
Analysis
18.6.7. Business
Strategies
18.7. PHARMACOSMOS
A/S
18.7.1. Company
Details
18.7.2. Company
Overview
18.7.3. Product
Offerings
18.7.4. Key
Developments
18.7.5. Financial
Analysis
18.7.6. SWOT
Analysis
18.7.7. Business
Strategies
18.8. Pieris
Pharmaceuticals, Inc.
18.8.1. Company
Details
18.8.2. Company
Overview
18.8.3. Product
Offerings
18.8.4. Key
Developments
18.8.5. Financial
Analysis
18.8.6. SWOT
Analysis
18.8.7. Business
Strategies
18.9. Rockwell
Medical, Inc.
18.9.1. Company
Details
18.9.2. Company
Overview
18.9.3. Product
Offerings
18.9.4. Key
Developments
18.9.5. Financial
Analysis
18.9.6. SWOT
Analysis
18.9.7. Business
Strategies
18.10. Sanofi
18.10.1. Company
Details
18.10.2. Company
Overview
18.10.3. Product
Offerings
18.10.4. Key
Developments
18.10.5. Financial
Analysis
18.10.6. SWOT
Analysis
18.10.7. Business
Strategies
18.11. Other
Market Participants
19. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
